PCNA and P53 expression in oral leukoplakia with different degrees of keratinization;Expressão do PCNA e P53 leucoplasias de mucosa jugal com diferentes graus de queratinização

Journal of Applied Oral Science

Volumn 14, Issue 4, 2006, Pages 276-280

  De Lawall, Mclaine Almeida ^a,b   Crivelini, Marcelo Macedo ^a  

^a Dental School   (Brazil)

^b NONE   (Brazil)

Author keywords

Immunohistochemistry; P53; Proliferating cell nuclear antigen (PCNA); Uniterms: Leukoplakia

Indexed keywords

EID: 58049175516     PISSN: 16787757     EISSN: 16787765     Source Type: Journal    
DOI: 10.1590/s1678-77572006000400012     Document Type: Article

References (30)

1. Axéll T, Holmstrup P, Kramer IR, Pindborg JJ, Shear M. International seminar- on oral leukoplakia and associated lesions related to tobacco habits: Lund University, Malino, Sweden, June 27-30. Community Dent Oral Epidemiol. 1984;12:145-54.
2. Axéll T, Pindborg JJ, Smith CJ, van der Waal I. Oral white lesions with special reference to precancerous and tobacco-related lesions: conclusions of an international symposium held in Uppsala, Sweden. 18-21 1994. J Oral Pathol Med. 1996;25(2):49-54.
3. Bánóczy J. Follow-up studies in oral leukoplakia. J Maxillofac Surg. 1977;5(1):69-75.
4. Bennett WP, Hollstein MC, He A, Zhu SM, Resau JH, Trump BF, et al. Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer. Oncogene. 1991;6(10):1779-84.
5. Birchall MA, Schock E, Harmon BV, Gobe G. Apoptosis, mitosis. PCNA and bel-2 in normal, leukoplakic and malignant epithelia of human oral cavity: prospective, in vivo study. Oral Oncol. 1997;33(6):419-25.
6. Bouquot JE, Gorlin. RJ. Leukoplakia. lichen planus, and other oral keratoses in 23,616 white Americans over the age of 35 years. Oral Surg Oral Med Oral Pathol. 1986;61(4):373-81.
7. Burkhardt A. Advanced methods in the evaluation of premalignant lesions and carcinomas of the oral mucosa. J Oral Pathol. 1985;14(10):751-78.
8. Castro AL. Estomatologia. São Paulo: Ed Santos; 2000.
9. Celis JE, Cells A. Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase. Proc Natl Acad Sci. 1985;82(10):3262-6.
10. Cruz IB, Snijders PJ, Meijer CJ, Braakhuis BJ, Snow- GB, Walboomers JM, et al. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma J Pathol. 1998;184(4):360-8.
11. Greenblatt MS, Bennett WP. Hollstein M, Harris CC. Mutations in the p53 tumor supressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 1994;54(18):4855-78.
12. Grinspan D. Enfermidades propias de las mucosas. In: Enfermidades de la boca: semiologia. patologia. clinica y terapeutica de la mucosa bucal. Buenos Aires: Mundi; 1973. p. 1465-517.
13. Huang WY, Coltrera M, Schubert M, Morton T, Truelove E, Histopathologic evaluation of proliferating cell nuclear antigen (PC10) in oral epithelial hyperplasias and premalignant lesions. Oral Surg Oral Med Oral Pathol. 1994;78(6):748-54.
14. Karabulut A, Reibel J, Therkildsen MH, Praetorius F, Nielsen HW, Dabelsteen E. Observer variability in the histologic assessment of oral premalignant lesions. J Oral Pathol Med. 1995;24(5):198-200.
15. Kollar JA, Finley CW, Nabers JM, Ritchey B, urban BJ. Leukoplakia. J Am Dent Assoc. 1954;49(5):538-48.
16. Kurki P, Ogata K, Tan EM. Monoclonal antibodies to proliferating cell nuclear antigen (PCNA)/cyclin as probes for proliferating cells by immunofluorescence microscopy and flow cytometry. J Immunol Methods. 1988;109(1):49-59.
17. Martinez-Lara I, Gonzalez-Moles MA, Ruiz-Avila I, Bravo M, Rainos MC, Fernandez-Martinez JA. Proliferating cell nuclear antigen (PCNA) as a marker of dysplasia in oral mucosa. Acta Stomatol Belg. 1996;93(1):29-32.
18. Pindborg JJ, Reibel J, Holmstrup B. Subjectivity in evaluating oral epithelial dysplasia. carcinoma in situ and initial carcinoma. J Oral Pathol. 1985;14(9):698-708.
19. Regezi JA, Zarbo RJ, Regev E, Pisanty S, Silverman S, Gazit D. p53 protein expression in sequencial biopsis of oral dysplasias and in situ carcinomas. J Ural Pathol Med. 1995;24(1):18-22.
20. Saito T, Nakajirna T, Mogi K. Immunohistochemical analysis of cell cycle-associated proteins p16. pRb. p53, p27 and Ki67 in oral cancer and precancer with special reference to verrucous carcinomas. J Oral Pathol Med. 1999;28(5):226-32.
21. Saranath D. Tandle AT, Teni TR, Dedhia PM, Borges AM, Parikh D, et al. p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India. Ural Oncol. 1999;35(3):242-50.
22. Sauter ER, Cleveland D, Trock B, Ridge JA, Klein-Szanto AJ. p53 is overexpressed in fifty percent of pre-invasive lesions of head and neck epithelium. Carcinogenesis. 1994;15(10):2269-74.
23. Schepman KP, van der Meij EH, Smeele LE, van der Waal I. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from the Netherlands. Oral Oncol. 1998;34(4):270-5.
24. Shin DM, Voravud N, Ro JY, Lee JS, Hong WK, Hittelman WN. Sequcncial increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potencial biomarker. J Nat Cancer Inst. 1993;85(12):971-8.
25. Shin DM, Kim J, Ro JY. Hittelman J, Roth JA, Hong WK, et al. Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res. 1994;54(2): 321-6.
26. Tsai ST, Jin YT. Proliferating cell nuclear antigen (PCNA) in oral squamous cell carcinomas. J Oral Pathol Med. 1995;24(7): 313-5.
27. Tsuji T, Mimura Y, Wen S, Li X, Kanckawa A, Sasaki K, et al. The significance of PCNA and p53 protein in some oral tumors. Int J Oral Maxillofac Surg. 1995;24(3):221-5.
28. van der Wall I, Schepman KP, van der Meij EH, Smeele LE. Oral leukoplakia: a clinicopathological review. Oral Oncol. 1997;33(5):291-301.
29. Warnakulasuriya S. Lack of molecular markers to predict malignant potencial of oral precancer. J Pathol. 2000;190(4):407-9.
30. Wright JM. A review and update of oral precancerous lesions. Tex Dent J. 1998;115(6):15-9.